Related Experiment Video
Updated: Mar 15, 2026

Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022
Rice-Fried and Sun-Dried Ginseng: A Comparative Study of Chemical Composition and Protective Effects Against
Qi Chu1, Yidan Zhang1, Junbao Li1
1School of Pharmacy, Changchun University of Chinese Medicine, Changchun 130117, China.
Rice-fried ginseng (RFG) demonstrates superior anti-inflammatory and anti-ulcerative colitis (UC) effects compared to sun-dried ginseng (SDG). RFG modulates gut microbiota and key signaling pathways, offering enhanced protection against UC.
Area of Science:
- Pharmacology and Traditional Chinese Medicine
- Gastroenterology and Immunology
- Natural Product Chemistry
Background:
- Ginseng (Panax ginseng) is a traditional Chinese medicine with anti-inflammatory and anti-ulcerative colitis (UC) properties.
- Rice-frying ginseng (RFG) processing is hypothesized to enhance its therapeutic effects by enriching rare ginsenosides.
Purpose of the Study:
- To compare the chemical composition of RFG and sun-dried ginseng (SDG).
- To evaluate the protective effects of RFG against UC in vitro and in vivo.
- To elucidate the underlying mechanisms of RFG's therapeutic action.
Main Methods:
- Chemical profiling of RFG and SDG using LC-MS and MS-DIAL.
- In vitro evaluation using lipopolysaccharide (LPS)-induced Caco-2 cells.
- In vivo assessment using dextran sulfate sodium (DSS)-induced UC mouse model.
- Metabolomics, network pharmacology, and Western blotting analyses.
Main Results:
- Rice-frying significantly altered ginseng's chemical composition, with 31 compounds increasing and 33 decreasing.
- RFG demonstrated enhanced protection in Caco-2 cells and DSS-induced UC mice, improving gut barrier integrity and reducing inflammation.
- RFG modulated gut microbiota, altered lipid metabolism, and inhibited PI3K-Akt and NF-κB signaling pathways.
Conclusions:
- RFG exhibits stronger anti-inflammatory and anti-UC effects than SDG.
- RFG's efficacy is linked to its altered chemical profile, modulation of gut microbiota and lipid metabolism, and inhibition of key inflammatory signaling pathways.
- RFG represents a promising therapeutic agent for ulcerative colitis.
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

